Deferasirox is an iron chelator and the first oral medication FDA approved for chronic iron overload in patients receiving long term blood transfusions.
Synonyms
Deferasirox
Deferasiroxum
Brand Names
Auro-deferasirox (type J)
Deferasirox oral
Deferasirox (type J)
Deferasirox Oral Granules
Taro-deferasirox (type J)
Sandoz Deferasirox (type J)
Deferasirox Mylan
PMS-deferasirox
Sandoz Deferasirox
Deferasirox Accord
Teva-deferasirox (type J)
Apo-deferasirox
Deferasirox
Taro-deferasirox
Teva-deferasirox
Deferasorox
Jadenu
Exjade
Apo-deferasirox (type J)
PMS-deferasirox (type J)
Jamp Deferasirox (type J)
Indication
For the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older.
Categories
Acids, Carbocyclic
Benzene Derivatives
Benzoates
Chelating Agents
Compounds used in a research, industrial, or household setting
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682